Biopharma and medtech deals: By the numbers
Ups and downs in life sciences deals could indicate a dynamic market this year.
2021 was another banner year for life sciences companies looking to make a deal. But it wasn’t all record-breaking highs. A few key ups and downs illustrate that biopharma and medtech firms are facing a market rife with change.